For Me. By Me. Unique Life-Enhancing Cell Therapies.

It Starts with Me! Innovative Therapy Created For Me.

It’s Specific to Me! A Passionate Commitment to Improving Each Patient’s Life.

Autologous Cell Therapy

Patients are the source of their own therapies. Their own tissue is processed and expanded into a specific cell or multi-cell therapy, then returned to the surgeon for implantation. Read More

Our Products

Vericel is committed to improving the lives of patients with serious medical conditions by developing and manufacturing unique cell therapies and specialty biologics. Read More

Investors

Integrity and accountability are the foundations of our efforts. We are committed to being open and transparent in our interactions with each other, our patients, and our investors. Read More

In The News

Learn about important upcoming events— including press releases, meetings, webcasts, stakeholder perspectives— and find answers to frequently asked questions. Read More

Advancing Autologous Cell Therapy for the Treatment of Serious Conditions

About Autologous Therapy

Autologous cell therapy uses a patient’s own cells for the treatment of a condition or disease. The cells are collected from the patient and expanded or multiplied outside the body, then reintroduced to the same patient. Advantages for this type of cell therapy include minimizing the risk of rejection and therefore the need for immunosuppressive therapy.

From Tissue to Treatment

  • Collection/Isolation: Physicians collect small target cell tissue samples from individual patients, then ship to a Vericel cGMP certified manufacturing site. The specific cell types are then isolated from the tissue based on the condition being treated.
  • Expansion/Implantation: Using well-validated techniques and growth factors, the cells are expanded several million times and prepared by the surgeon for implantation into the same patient.

Vericel is currently marketing a robust therapy portfolio targeting areas of significant medical need See our product pipeline



Investor Relations

Here is your resource for financial information about Vericel Corporation. In this section you will find information about our current and historical share price, SEC filings, electronic version of our annual report, frequently asked questions, as well as forms to request additional information.

NASDAQ: VCEL

$2.40 0.05 (2.13%)
Day High: 2.500
Day Low: 2.350
Volume: 669,235
3:59 PM on
December 02, 2016

Delayed ~20 min., by eSignal.

Company Presentation